Complexion type | sensitive |
Effects | Calming, Anti-redness |
Sun Protection | without SPF |
When to use | day and night |
Soothe your skin instantly and feel the comfort all day long
Reveal calmer, healthier-looking skin with every use. BIODERMA Sensibio AR+ Cream instantly calms and fortifies your skin barrier while delivering up to 24 hours of hydration. Designed to reduce redness and minimise the appearance of small blood vessels, it leaves your complexion even-toned and comforted. Its formula is dermatologically and ophthalmologically tested, ensuring safety for sensitive skin. Its non-greasy, non-sticky texture makes it an excellent makeup base, providing a smooth and balanced finish.
Characteristics:
- instantly soothes and strengthens skin barrier
- diminishes redness and small vessels visibility
- moisturises the skin for up to 24 hours
- lightweight texture that can be used as a makeup based
- doesn’t leave a greasy or sticky residue
- dermatologically and ophthalmologically tested
Ingredients:
- DAF™ (Dermatological Advanced Formulation) TECHNOLOGY – improves sensitive skin’s tolerance
- ROSACTIV™ 2.0 PATENTED TECHNOLOGY – targets sources of rosacea
- biomimetic lipid – helps to strengthen the skin’s barrier function
- contains 88.7% biomimetic ingredients
- free of fragrance
How to apply:
Apply BIODERMA Sensibio AR+ Cream morning and evening on clean skin of your face, neck, and eyelids.
This text was created with the help of AI and may therefore contain errors.
Special offers
New
40 ml
€25.00
The lowest price this product has been offered at in the last 30 days before the start of this offer/sale. More information
€23.60
Sale price valid for a limited time
-5%
Free delivery from
€85.00
Valid for categories Fragrance, Home Fragrance and
more
Free delivery is applied automatically in your shopping basket when your items meet the criteria.

Get a sample plus 4 more of your choice.
In stock | €59.00 / 100 ml, incl. VAT | Code: BIR03798
1
Express Delivery
Monday 24/3/2025
DPD Tracked Delivery
Thursday 27/3/2025